# Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia

> **NCT05098249** · PHASE4 · COMPLETED · sponsor: **Donat R. Spahn** · enrollment: 92 (actual)

## Conditions studied

- Anemia
- Iron-deficiency
- Hypophosphatemia

## Interventions

- **DRUG:** Verum
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05098249
- **Lead sponsor:** Donat R. Spahn
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-11
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-23
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05098249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05098249, "Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05098249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*